Biomarker patterns in patients with cardiogenic shock versus septic shock

Area of Science:

• Cardiology
• Critical Care Medicine
• Biomarker Research

Background:

• Cardiogenic shock (CS) involves contractile failure often with systemic inflammation.
• Septic shock (SS) frequently presents with cardiac dysfunction.
• Current hemodynamic support strategies for CS and SS are often similar, despite differing pathophysiological profiles.

Purpose of the Study:

• To compare neurohormonal activation and cardiovascular stress biomarkers in patients with CS and SS.
• To determine if biomarker profiles differ between CS and SS.
• To assess the prognostic value of biomarkers in each shock type.

Main Methods:

• A prospective, multicenter cohort study matched 111 CS patients with SS patients.
• Clinical data and blood samples were collected within the first 1-3 days of ICU admission.
• Biomarker concentrations were analyzed to assess neurohormonal activation and cardiovascular stress.

Main Results:

• The study included 222 patients (mean age 61 years, 37% male).
• Thirty-day mortality rates were similar between CS (40.5%) and SS (43.1%).
• While SS patients had higher overall biomarker concentrations, only CS patients showed biomarker concentrations associated with mortality.

Conclusions:

• Septic shock and cardiogenic shock patients exhibit comparable baseline characteristics and mortality.
• Biomarker profiles differ between CS and SS, with prognostic value primarily observed in CS.
• These findings suggest a need for tailored biomarker assessment and potentially distinct therapeutic approaches for CS versus SS.